Efficacy of DIMS spectacle lenses among non-responders to 0.01% low dose Atropine.

HOYA Holdings0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1) Children with myopia of SE between -0.50 D and -10.00 D (combination of -6.00DS and -4.00 DC) of age group 6-12 years
•2) Documented history of myopia progression by more than - 0.50D and/or increase in axial length by more than 0.20mm between 6 months to one year while using 0.01% atropine once daily
•3) Corrected VA is = 0.1 Log MAR or 0.8 in Snellen.

•1) Prior use of 0.01% low dose atropine twice a day
•2) History of any previous myopia control intervention other than 0.01% low dose atropine
•3) History of any ocular or systemic disease
•4) History of any previous ocular surgery or trauma
•5) Anisometropia > - 2.00 D; Astigmatism > - 1.50 D and Amblyopia
•6) Any hypersensitivity/allergic reaction with use of 0.01% atropine
•7) Myopia of higher than -8.00D (limited by availability of DIMS spectacle lens in power higher than that)

发起方

HOYA Holdings